companydata.dkcompanydata.dk

Thermo Fisher Diagnostics ApS: Financial statements 2025

CVR: 27640745

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Thermo Fisher Diagnostics ApS (CVR 27640745) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 34,059,000 and a net result of DKK 5,450,000 compared with DKK 6,358,000 the year before. That is an increase of 23.6% compared with the year before. Equity in the 2025 report amounted to DKK 74,863,000. The solvency ratio was 70.8%. The company had 27 employees in the financial year.

Gross Profit
DKK 34,059,000
Profit/Loss
DKK 5,450,000
Equity
DKK 74,863,000
Total Assets
DKK 105,789,000
Employees
27

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-34.1M5.5M74.9M27
2024-27.6M6.4M69.4M25
2023-31.4M6.6M63.1M31
2022-44.1M12.6M56.5M28
2021-33.1M1.2M43.9M31

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Thermo Fisher Diagnostics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Thermo Fisher Diagnostics ApS: The 2024 annual report is outJul 16, 2025

Thermo Fisher Diagnostics ApS has published its annual report for 2024. Gross profit came to DKK 27,565,000, and the net result was DKK 6,358,000.

Thermo Fisher Diagnostics ApS wins public contractMar 18, 2025

Thermo Fisher Diagnostics ApS has won the tender "Next Generation Sequencing (NGS) udstyr til Patologi på AUH" issued by Region Midtjylland worth 10,000,000 DKK.

About Thermo Fisher Diagnostics ApS

Thermo Fisher Diagnostics ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2004. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named PHADIA ApS and SWEDEN DIAGNOSTICS (DENMARK), ApS. The management consists of Pia Finnemann-Andersen. The board consists of Petrus Thomas Adrianus van der Zande (chair), Pia Finnemann-Andersen and Simon Lie. The company is owned by Thermo Fisher Scientific Beteiligungsverwaltungs GmbH. The company has 24 employees (2026). In 2025, the company reported a gross profit of DKK 34,059,000 and a net result of DKK 5,450,000 compared with DKK 6,358,000 the year before. Equity in the 2025 report amounted to DKK 74,863,000.

Source: annual report 2025, Danish Business Authority